JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 166 filers reported holding JUNO THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 1.25 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $40,470,000 | -33.6% | 2,146,963 | +5.7% | 0.01% | -46.2% |
| Q3 2016 | $60,972,000 | -19.3% | 2,031,736 | +3.4% | 0.01% | -23.5% |
| Q2 2016 | $75,512,000 | +30.6% | 1,964,403 | +29.5% | 0.02% | +30.8% |
| Q1 2016 | $57,799,000 | -1.1% | 1,517,425 | +14.1% | 0.01% | 0.0% |
| Q4 2015 | $58,462,000 | +879.1% | 1,329,599 | +806.0% | 0.01% | +550.0% |
| Q3 2015 | $5,971,000 | +21.8% | 146,747 | +59.7% | 0.00% | +100.0% |
| Q2 2015 | $4,901,000 | +5.1% | 91,904 | +19.5% | 0.00% | 0.0% |
| Q1 2015 | $4,665,000 | – | 76,903 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 25,948,799 | $1,132,937,000 | 100.00% |
| Biomark Capital Management Co. LLC | 1,602,562 | $70,465,000 | 85.76% |
| Omega Fund Management, LLC | 1,229,512 | $54,062,000 | 30.09% |
| Clarius Group, LLC | 218,942 | $9,626,000 | 2.93% |
| BB BIOTECH AG | 1,305,000 | $57,381,000 | 1.62% |
| Casdin Capital, LLC | 17,500 | $769,000 | 0.68% |
| Rock Springs Capital Management LP | 197,001 | $8,662,000 | 0.66% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 38,850 | $1,708,000 | 0.55% |
| ArrowMark Colorado Holdings LLC | 383,749 | $16,873,000 | 0.46% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 68,848 | $3,027,000 | 0.38% |